The Influence of IS 1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease
Elisabeth Kugelberg, Bridget Gollan, Christopher Farrance et al. · 2010
Read The Influence of IS 1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease by Elisabeth Kugelberg, Bridget Gollan, Christopher Farrance et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009413.txt.
Introduction
Elisabeth Kugelberg and co-authors published this meningitis study in PLOS ONE in 2010. Neisseria meningitidis is a bacterium that can ride harmlessly in the throat or cause deadly disease. A mobile DNA piece called IS1301 sometimes lands in its capsule-making region. In Spanish group C strains, that insertion made the bacteria harder for the immune system to kill.
The team investigated what IS1301 does in the same spot more broadly. They looked at both carriage in healthy people and invasive disease. A small DNA insertion that shifts that balance matters for vaccines and outbreak tracking. It shows how one jump of DNA can change a germ's character.
Catalog record
| CREATOR | Elisabeth Kugelberg, Bridget Gollan, Christopher Farrance et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009413
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Influence of IS 1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease Authors: Elisabeth Kugelberg, Bridget Gollan, Christopher Farrance, Holly Bratcher, Jay Lucidarme, Ana Belén Ibarz-Pavón, Martin C. J. Maiden, Ray Borrow, Christoph M. Tang Published: 2010, PLOS ONE DOI: 10.1371/journal.pone.0009413 ABSTRACT Previously we have shown that insertion of IS 1301 in the sia / ctr intergenic region (IGR) of serogroup C Neisseria meningitidis (MenC) isolates from Spain confers increased resistance against complement-mediated killing. Here we investigate the significance of IS 1301 in the same location in N. meningitidis isolates from the UK. PCR and sequencing was used to screen a collection of more than 1500 meningococcal carriage and disease isolates from the UK for the presence of IS 1301 in the IGR. IS 1301 was not identified in the IGR among vaccine failure strains but was frequently found in serogroup B isolates (MenB) from clonal complex 269 (cc269). Almost all IS 1301 insertions in cc269 were associated with novel polymorphisms, and did not change capsule expression or resistance to human complement. After excluding sequence types (STs) distant from the central genotype within cc269, there was no significant difference for the presence of IS 1301 in the IGR of carriage isolates compared to disease isolates. Isolates with insertion of IS 1301 in the IGR are not responsible for MenC disease in UK vaccine failures. Novel polymorphisms associated with IS 1301 in the IGR of UK MenB isolates do not lead to the resistance phenotype seen for IS 1301 in the IGR of MenC isolates. INTRODUCTION The exclusively human pathogen Neisseria meningitidis causes serious diseases including septicaemia and bacterial meningitis. However, it is primarily a commensal of the human nasopharynx in around 10% of healthy individuals [1] , [2] . Rarely, the bacterium overcomes host defences, especially the complement system, and causes bloodstream infection, septic shock and/or meningitis. The meningococcus can express one of 13 capsules (classifying isolates into serogroups) that are necessary for avoidance of complement-mediated killing [3] . Isolates are also categorised into sequence types (STs) based on sequences of seven housekeeping genes [4] . Most disease is caused by a limited number of genotypes, while other genotypes seldom invade the bloodstream [5] . Clonal complexes (cc) are groupings of STs with similar allelic profiles typically sharing at least 4–5 loci ( http://pubmlst.org/neisseria ). Recently we described a polymorphism in three serogroup C ST-11 N. meningitidis isolates (MenC) from Spain that enhances resistance against complement-mediated killing, the principal mechanism of immunity against meningococcal disease [6] . In all isolates, IS 1301 was found in the 134 bp intergenic region (IGR) between operons for capsule biosynthesis ( sia ) and export ( ctr ) ( Figure 1A ), leading to up-regulation of capsule expression and providing a generic mechanism for increased resistance against bactericidal antibodies. A: The transcription initiation site (Ti) is indicated [28] as well as the insertion of IS 1301 in the IGR. The two most common polymorphic IGR with IS 1301 , IS-8 and iIS+69, are also illustrated. B: Isogenic strains with and without the polymorphisms associated with IS 1301 were constructed by tagging the nmb76 gene downstream of the ctr operon with a kanamycin resistance (kan R ) cassette. C: The 8 bp deletion associated with IS 1301 in the IGR; i) wild-type sequence, and ii) to iv) shows the 8 bp deletion with associated base pair changes (indicated in bold and lower case). * Refers to the most common type of IS-8, which was used for phenotypic analysis. The sequence denotes the base pairs from the insertion site of IS 1301 up to the siaA translational start (underlined). The MenC glycoconjugate vaccine has been very effective, leading to >90% reduction of MenC cases in countries where it has been introduced [7] – [10] . So far there has been no evidence of emergence of strains that are resistant to the immune responses elicited by the vaccine. However, there are a few reports of MenC disease developing in subjects who have completed a course of immunisation [11] , [12] , and these could be caused by strains with increased resistance to complement-mediated killing due to insertion of IS 1301 in the sia / ctr IGR. Furthermore, increased resistance to complement-mediated killing conferred by IS 1301 could promote meningococcal virulence. Here we investigate whether isolates with IS 1301 in the IGR are emerging among vaccine failure strains, and compare its presence in UK carriage and disease isolates. RESULTS IS 1301 in the sia / ctr IGR was originally described in MenC isolates in Spain; isolates had low titre (<8) in serum bactericidal assays (SBA) using sera from individuals immunised with the MenC conjugate vaccine [6] . As an SBA titre of <8 is a marker of protective immunity [13] , [14] , we examined MenC isolates from individuals from the UK with meningococcal disease who had completed a course of the MenC conjugate vaccine [11] , [15] . Most isolates were ST-11 (79%; 26 out of 33, with the others were ST-1095 [two isolates], ST-8, ST-2709, ST-467, ST-3463 and ST-6331), the most common cause of MenC disease at the time of the introduction of the vaccine [16] . IS 1301 was not present in the IGR of any of the 33 MenC isolates, even though most isolates (32 out of 33) have IS 1301 elsewhere in the genome (data not shown). We also examined MenC disease isolates in the UK before the introduction of the MenC conjugate vaccine (1998–99), and found IS 1301 in the IGR in less than 1% of the isolates (1 out of 104 isolates, Table 1 ); IS 1301 was inserted at the same location but in the opposite orientation (inverted) to the ST-11 isolates from Spain [6] . Therefore, there is currently no evidence from the UK that IS 1301 in the IGR mediates a mechanism for escape from the MenC conjugate vaccine. P-value was calculated using Fischer's exact test. NG, non-groupable. TABLE: Presence of IS 1301 in the IGR of UK disease and carriage isolates from South East England. Serogroup Disease Carriage P-value a Total + IS 1301 Total + IS 1301 B 209 30 (14%) 175 11 (6%) 0.01 C 104 1 (<1%) 16 0 W135 15 0 53 0 Y 5 0 46 0 A 1 0 0 0 X 1 0 10 0 Z 0 0 6 0 29E 1 0 70 0 NG b 9 2 365 0 Total 345 33 (10%) 741 11 (1%) <0.0001 PRESENCE OF IS 1301 IN THE IGR OF UK MENINGOCOCCAL DISEASE AND CARRIAGE ISOLATES Enhanced resistance to human sera may promote the virulence of N. meningitidis during infection, and therefore insertion of IS 1301 in the IGR might be more frequent among meningococcal disease compared to carriage isolates. We examined 741 carriage and 345 disease isolates of different serogroups collected between 1998 and 2000 in the South East of England ( Table 1 , [17] , [18] ). In this collection, insertion of IS 1301 was significantly more frequent in the IGR of disease (10%; 33 out of 345) compared to carriage isolates (1.5%; 11 out of 741, p<0.0001, Table 1 ). Approximately 50% of the carriage isolates